UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye inflammation breakdown: which biologic works best?
Disease control CompletedThis study tested three biologic drugs (adalimumab, anakinra, and tocilizumab) in 112 people with a severe eye condition called non-infectious uveitis that did not improve with standard treatments. The goal was to see which drug best controls inflammation and reduces the need for…
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New imaging study tracks eye inflammation treatment in detail
Knowledge-focused CompletedThis study followed 30 people with uveitis, an eye inflammation condition, who received a fluocinolone acetonide implant. Researchers used special eye scans to measure inflammation over 12 months. The goal was to see if these scans can better track how well the treatment works co…
Matched conditions: UVEITIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC